Agreement Combines Tenaya’s Expertise in Identification and Validation of Genetic Heart Disease Targets with Alnylam’s Ability to Deliver Transformational Therapeutics Tenaya to Receive Up to $10 ...
The alliance, which pairs Tenaya’s modality agnostic target identification and validation capabilities with Alnylam’s deep experience in RNA interference therapeutics, comes during a period of ...
New therapeutics in development for autoimmune disease and oncology Lead therapeutic BRZ-101 designed to restore immune tolerance in type 1 diabetes, advancing into IND-enabling studies Expanding ...
The Druzhba pipeline is currently damaged. China’s great green wall: How 66 billion trees turned a 'dead' desert into a carbon sink Dubai wasn't in the war — then why did Iran attack Gulf's glittering ...
Federal and local authorities will use genetic genealogy to analyze DNA found at Nancy Guthrie’s home as the ongoing investigation into her possible abduction stretches into its third week. The ...
The industries that design, construct and maintain our built world are facing a workforce crisis that’s very real and very immediate. Whether concrete specialists, HVAC technicians, surveyors, ...
LONDON, Feb 2 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday that its experimental genetic disorder treatment showed promise in a late-stage study of patients with a type ...
Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in early-to-mid-stage development for treating certain hematology and genetic diseases. The ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Federal Energy Regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results